Response to three doses of the Pfizer/BioNTech BNT162b2 COVID-19 vaccine: a retrospective study of a cohort of haemodialysis patients in France

BACKGROUND: The mortality rate associated with coronavirus disease 2019 (COVID-19) is high among haemodialyzed patients. We sought to describe the serological status of haemodialysis patients having received up to three doses of BNT162b2 mRNA vaccine, and to identify factors associated with a poor h...

Descripción completa

Detalles Bibliográficos
Autores principales: Verdier, Jean-François, Boyer, Sonia, Chalmin, Florence, Jeribi, Ahmed, Egasse, Caroline, Maggi, Marie France, Auvray, Philippe, Yalaoui, Tarik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116059/
https://www.ncbi.nlm.nih.gov/pubmed/35585512
http://dx.doi.org/10.1186/s12882-022-02751-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116059/
https://www.ncbi.nlm.nih.gov/pubmed/35585512
http://dx.doi.org/10.1186/s12882-022-02751-5

Ejemplares similares